Chokri Ben Lamine: A Two-Day Journey Through Modern Hematology at KFSHRC
Chokri Ben Lamine, Hematologist at King Faisal Specialist Hospital and Research Center, shared a post on LinkedIn:
”Advancing Hematology Through Shared Expertise | KFSHRC Center of Excellence Clinical Hematology Meeting
King Faisal Specialist Hospital and Research Centre, Riyadh
KACOLD, Level 1 — Executive Meeting Room
30 September–1 October 2026
The KFSHRC Center of Excellence in CLL preceptorship brings together a comprehensive two-day program covering CLL, leukemia, lymphoma, myeloma and cellular therapy—with practical discussions connecting clinical evidence to everyday patient care.
Opening sessions
Feras Alfraih delivers the welcome address, followed by Hazzaa Alzahrani’s overview of KFSHRC and the Cancer Centre of Excellence.
Day 1 | CLL and Leukemia
Infection prevention, vaccination and antimicrobial prophylaxis in the era of novel agents — Maha Alamri
CLL diagnosis and prognostic markers — Mohamed Masoud
Treatment-naïve CLL — Omar Albanyan
Relapsed/refractory CLL and subsequent treatment lines — Marwan Shaheen
CLL case discussions and real-world challenges — Naeem Chaudhri
Future directions in CLL management, including ASH/EHA developments — Mansour Alfayez
Clinical vignettes in mantle cell lymphoma — Waleed Rasheed
How I treat ALL in 2026 — Amr Hanbali
Day 2 | Lymphoma, Myeloma and Cellular Therapy
Antibody–drug conjugates, T-cell engagers and CAR-T in ALL — Hanan Alkhaldi
DLBCL diagnosis and prognostic markers — Dr. Khalid Alghamdi
How I treat DLBCL in 2026 — Alfadel Alshaibani
Richter transformation — Ahmed Alnughmush
T-cell engagers versus CAR-T in DLBCL — Abdulwahab Albabtain
CAR-T clinical evidence and the KFSHRC experience — Syed Osman
Recognizing and managing CLL drug toxicities — Hadeel Samarkandi
The clinical research model at KFSHRC — Riad Elfakih
Multiple myeloma: novel agents and the role of CAR-T — Abdullah Alamer
Beyond the lectures, the program includes a hospital tour spanning clinical care, research, pathology, data services and innovation, alongside networking and interactive discussion.
An opportunity to exchange experience, discuss challenging cases and strengthen collaboration in hematologic cancer care.
Appreciation to the organizers and faculty for sharing their expertise.”
Other posts featuring Chokri Ben Lamine on Hemostasis Today.
-
Oct 2, 2026, 18:34Kamini Khillan: Massive Transfusion Protocol for PPH Management
-
Oct 2, 2026, 18:24Garima Sharma։ GLP-1 Receptor Agonists Across the Reproductive Life Course
-
Oct 2, 2026, 18:13Priya Sriskandarajah: Roginolisib Plus JAK Inhibitors in Myelofibrosis
-
Oct 2, 2026, 17:27Reza Shojaei: The Invisible Crisis, Part 1- Donor Deferral in Whole Blood
-
Oct 2, 2026, 16:02Advancing Antithrombotic Stewardship to Optimise Care – American Heart Association
-
Oct 2, 2026, 15:37Pall T. Onundarson: Monitoring Warfarin Beyond Factor VII
-
Oct 2, 2026, 15:26Nicola Carter: World Thrombosis Day Highlights Gender Specific Risks and Prevention
-
Oct 2, 2026, 14:56Wolfgang Miesbach: Direct Comparison Reveals Distinct Mechanisms Among FVIIIa Mimetics
-
Oct 2, 2026, 14:47Strengthening Hemophilia Care Through Advocacy and Partnership – World Federation of Hemophilia